Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus · 2026
The relationship between maternal cannabis use disorder diagnosis and the development of retinopathy of prematurity.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tran Melanie D, Baer Rebecca J, Bandoli Gretchen, Robbins Shira L, Granet David, Chambers Christina D, Rudell Jolene C
Аннотация
PURPOSE: To compare the incidence of retinopathy of prematurity (ROP) among preterm infants born to mothers with and without a cannabis use disorder (CUD) diagnosis.
METHODS: This retrospective cohort study used the UC San Diego Study of Outcomes in Mothers and Infants (SOMI) population-based database and restricted the sample to infants born between 22 and <31 weeks' gestation, and/or having birth weight of <1500 g, who survived to the appropriate age for ROP screening. Infant ROP and maternal CUD during pregnancy were identified from International Classification of Diseases diagnostic codes from hospital discharge records. Adjusted relative risk (aRR) of ROP was calculated using log-linear regression, comparing mothers with and without CUD while controlling for demographic and clinical factors.
RESULTS: Of the 997 infants born between 22 and <31 weeks to mothers with CUD, 32.1% developed ROP, compared with 33.3% of the 30,1113 infants born to mothers without CUD. Adjusting for maternal covariates, preterm infants born to mothers with CUD were not found to be at higher or lower risk of developing ROP than preterm infants born to mothers without CUD (aRR = 1.0; 95% CI, 0.9-1.1).
CONCLUSIONS: In our study cohort, preterm infants born to mothers with CUD did not have an increased or decreased risk of developing ROP compared with those born to mothers without CUD.
METHODS: This retrospective cohort study used the UC San Diego Study of Outcomes in Mothers and Infants (SOMI) population-based database and restricted the sample to infants born between 22 and <31 weeks' gestation, and/or having birth weight of <1500 g, who survived to the appropriate age for ROP screening. Infant ROP and maternal CUD during pregnancy were identified from International Classification of Diseases diagnostic codes from hospital discharge records. Adjusted relative risk (aRR) of ROP was calculated using log-linear regression, comparing mothers with and without CUD while controlling for demographic and clinical factors.
RESULTS: Of the 997 infants born between 22 and <31 weeks to mothers with CUD, 32.1% developed ROP, compared with 33.3% of the 30,1113 infants born to mothers without CUD. Adjusting for maternal covariates, preterm infants born to mothers with CUD were not found to be at higher or lower risk of developing ROP than preterm infants born to mothers without CUD (aRR = 1.0; 95% CI, 0.9-1.1).
CONCLUSIONS: In our study cohort, preterm infants born to mothers with CUD did not have an increased or decreased risk of developing ROP compared with those born to mothers without CUD.